Trademark: 79298417
Word
CELYAD ONCOLOGY
Status Date
Tuesday, January 25, 2022
Registration Number
6624226
Registration Date
Tuesday, January 25, 2022
Filing Date
Thursday, October 15, 2020
Published for Opposition
Tuesday, November 9, 2021
5 Cellular pharmaceutical preparations for use in oncology and cardio-vascular diseases; implants comprised of living tissues, for pharmaceutical use; pharmaceutical products, namely, products for the treatment of tumors and cardio-vascular diseases; living tissue in the nature of chimeric antigen receptor (CAR-T) cells for medical use; compositions comprised of white blood cells, specifically T-cells and NK-cells, for pharmaceutical use; viral vectors in the nature of biological cultures for medical use; plasmids in the nature of DNA molecules for medical use
10 Bioreactors for medical analysis; apparatus for culture, proliferation and modification of human cells for medical purposes; apparatus for cell therapy; catheters; surgical and medical instruments for use in the diagnosis and treatment of oncology and cardio-vascular diseases; medical implants consisting of artificial materials
42 Scientific and technological services, namely, research, analysis and testing in the field of oncology and cardio-vascular diseases; scientific research services in the field of cell therapy, oncology, immuno-oncology and in the field of medical and surgical instruments
The mark consists of the dark blue stylized wording "CELYAD ONCOLOGY" appearing to the right of four translucent overlapping semi-circles forming a spiral; the bottom semi-circle is gray; the next overlapping semi-circle is dark turquoise and turquoise; the next overlapping semi-circle is dark purple, purple and pink; the last and top overlapping semi-circle is dark maroon, maroon, red and orange.
The colors dark blue, gray, dark turquoise, turquoise, dark purple, purple, pink, dark maroon, maroon, red, and orange are claimed as a feature of the mark.
"ONCOLOGY"
Jul 25, 2022
Final Decision Transaction Processed By Ib
Jul 1, 2022
Final Disposition Notice Sent To Ib
Jul 1, 2022
Final Disposition Processed
Apr 25, 2022
Final Disposition Notice Created, To Be Sent To Ib
Jan 25, 2022
Registered-Principal Register
Nov 9, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 9, 2021
Published For Opposition
Oct 20, 2021
Notification Of Notice Of Publication E-Mailed
Oct 1, 2021
Approved For Pub - Principal Register
Oct 1, 2021
Examiner's Amendment Entered
Oct 1, 2021
Notification Of Examiners Amendment E-Mailed
Oct 1, 2021
Examiners Amendment E-Mailed
Oct 1, 2021
Examiners Amendment -Written
Sep 22, 2021
Teas/Email Correspondence Entered
Sep 21, 2021
Correspondence Received In Law Office
Sep 21, 2021
Teas Response To Office Action Received
Apr 13, 2021
Refusal Processed By Ib
Mar 24, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Mar 24, 2021
Refusal Processed By Mpu
Mar 20, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Mar 19, 2021
Non-Final Action Written
Mar 16, 2021
Assigned To Examiner
Dec 4, 2020
Application Filing Receipt Mailed
Nov 30, 2020
New Application Office Supplied Data Entered In Tram
Nov 26, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
